Results 51 to 60 of about 36,213 (158)

Unresectable Primary Enteric‐Type Thymic Adenocarcinoma Treated With FOLFOX Chemotherapy: A Case Report

open access: yesCancer Reports, Volume 8, Issue 9, September 2025.
ABSTRACT Background Enteric‐type thymic adenocarcinomas are an extremely rare and distinct subtype of thymic malignancies, as classified by the 2021 World Health Organization classification of thymic tumors. These tumors exhibit close molecular and morphologic similarity to primary gastrointestinal malignancies. To date, there are no tailored treatment
Carl He   +3 more
wiley   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 226-242, May/June 2025.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid   +6 more
wiley   +1 more source

Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 3, March 2025.
The thera(g)nostic approach with somatostatin analog‐based agents extends beyond gastroenteropancreatic neuroendocrine tumors. Understanding tumor biological mechanisms is essential for optimizing treatment strategies. Abstract First isolated by Brazeau et al. in 1972, somatostatin (SST) is a neuropeptide known for regulating various signaling pathways
Giulia Santo   +3 more
wiley   +1 more source

Early-life nutritional and environmental determinants of thymic size in infants born in rural Bangladesh [PDF]

open access: yes, 2009
The aim was to assess the impact of nutritional status and environmental exposures on infant thymic development in the rural Matlab region of Bangladesh.
Collinson, A. C.,   +34 more
core   +1 more source

Recurrent Thymic Carcinoma Treated With Median Sternotomy, Innominate Vein Replacement for Superior Vena Cava, and Iodide Implantation: A Case Report and Review of the Literature

open access: yesCancer Reports, Volume 8, Issue 1, January 2025.
ABSTRACT Background Neuroendocrine tumors of the thymus (NETT) are rare and malignant tumors that arise in the anterior mediastinum. These tumors can exhibit aggressive behavior and may involve surrounding critical structures, such as the superior vena cava.
Zhong‐zheng Chen   +3 more
wiley   +1 more source

Thymic carcinoid with multiple endocrine neoplasia type 1: a case report

open access: yes, 2013
Thymic carcinoid is a rare neuroendocrine tumor of the thymus. Apart from sporadic cases, it is usually associated with multiple endocrine neoplasia type 1 (MEN1).
Celik, ALİ   +4 more
core   +1 more source

Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development [PDF]

open access: yes, 2011
Dendritic cells (DCs) in the thymus (tDCs) are predominantly accumulated in the medulla and contribute to the establishment of self-tolerance. However, how the medullary accumulation of tDCs is regulated and involved in self-tolerance is unclear. We show
Ishimaru, N.   +36 more
core   +1 more source

Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease

open access: yes, 2022
The incidence of neuroendocrine tumors (NET) is 2.5–5 per 100 000 population. Up to 20% of patients with NET develop carcinoid syndrome (CS), and in 40–50% of those carcinoid heart disease (CHD) is reported (0.27 per 100 000 population per year) [1 ...
Uladzimir Andrushchuk   +3 more
core   +1 more source

Thymic neoplasms patients complicated with bronchiectasis: Case series in a Chinese hospital and literature review

open access: yesThoracic Cancer, 2019
Background Bronchiectasis is a rare complication in patients with thymic neoplasm. The aim of this study was to investigate the clinical and radiological manifestations, laboratory tests, pathologic features, and outcome of treatment of bronchiectasis in
Yongjian Liu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy